RNL Preview with Dr. Lisa Sammaritano: Anti-Rheumatic Drug Use with Pregnancy
RheumNow Live Preview with Dr. Lisa Sammaritano on Anti-Rheumatic Drug Use During Pregnancy.
A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.
Hypertension is one of the many comorbidities that plagues gout patients.
Dr. John Cush RheumNow
7 years 4 months ago
#EULAR2019 Emapalumab - a monoclonal Ab against IFNγ - was shown to be effective in 6 systemic JIA patients with macrophage activation syndrome. Rx led to rapid neutralization of IFNγ, normalization of CXCL9, & decreased T cell activation. OP0204 https://t.co/5K58IUNdCV
Dr. John Cush RheumNow
7 years 4 months ago
A survey of 900 Danish rheumatic dz pts shows that 1 in 10 with pain have considered suicide in the last 4 weeks and that this was strongly influenced by poor quality sleep. #EULAR2019 OP0347 https://t.co/hfIWXEC4Xo
Recommendations for the screening, diagnosis, and treatment of various diseases often differ by organization, making it difficult to know which ones to follow.
Research published in PNAS has shown that long after active Lyme infection in the joint, a peptidoglycan (PG) of the the spirochete Borrelia burgdorferi can be found in the joints of those with late-stage Lyme disease.
Rheumatoid arthritis patients taking tofacitinib (Xeljanz) plus methotrexate who achieved low disease activity (LDA) may be able to withdraw from the latter agent without significant worsening of disease activity, a researcher reported at EULAR 2019 in Madrid.
Gout Study Group GoutGroup
7 years 4 months ago
#EULAR2019 Come hear the latest on gout! Room N103 16:15-17:45 today. Risk:Exciting new genetics, occupational hazard, diet and inflammation. Treatment: New effectiveness measure, DECT to diagnose, flare prophylaxis, treat to target to prevent increased mortality @rheumnow #gout
Gout Study Group GoutGroup
7 years 4 months ago
#Gout and #genetics at #EULAR2019. New data on genes linked to sUA regulation and leading-edge genetics on conversion from #hyperuricemia to gout were shown in talks OP47 and OP48 @Rheumnow https://t.co/d6pikodu6K
Gout Study Group GoutGroup
7 years 4 months ago
A study examined whether EGCG suppresses the activation of the NLRP3 inflammasome, thereby effectively preventing gouty #inflammation. It was found that EGCG reduces inflammation in mouse foot tissue making it a promising treatment option for #gout https://t.co/X9O2mbJx6A https://t.co/wgUYz0BmeY
Victoria Romero romeropazosvic
7 years 4 months ago
PARE poster tour II: @SjogrenpowerAna presenting poster “Patient Voice in Gout: A European Patient Survey to understand the needs of people living with #gout” #agony (37%) #frustation (32%) inconvenience (53%) & 10% of patients have retired because of gout #Time2Work #EULAR2019 https://t.co/qUQoYt3nKL
Gout Study Group GoutGroup
7 years 4 months ago
Achilles’ tendon issues can be painful and disabling, and are something we all want to avoid. Dr Simon Otter presents imaging data at #EULAR2019 showing loss of Achilles’ tendon stiffness-ability to bear load-in the gout patients in his cohort. Abstract SAT0727 #gout @RheumNow https://t.co/yxhcpQsGBi
David Liew drdavidliew
7 years 4 months ago
It’s been a fantastic meeting - this is me, signing off from #EULAR2019 in Madrid! @RheumNow https://t.co/iYAcClaFMR https://t.co/JQkXXNqdVN
EULAR | The European League Against Rheumatism eular_org
7 years 4 months ago
That’s a wrap! Thank you to all delegates, speakers, submitters and exhibitors for making #EULAR2019 unforgettable! https://t.co/RSa6DkCPt1
The Journal of Rheumatology jrheum
7 years 4 months ago
And off we go. Thank you #EULAR2019. Thank you #Madrid. What a beautiful city. We enjoyed seeing our friends on this side of the planet for a change. We look forward to Frankfurt 2020. Adiós! https://t.co/vT8bURmkpJ
